IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.

IDEXX provides diagnostic and software products and services for pet healthcare, self-described as a global leader in veterinary innovation.

IDEXX

IDEXX Animana

ezyVet

IDEXX Small Animal Health

IDEXX Water Testing

Livestock Diagnostics

10,000 people, one global focus﻿ - enhancing the health and well-being of pets, people, and livestockWe are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.

Metric
Company Name	IDEXX Laboratories, Inc.
Symbol	IDXX
MSH ID	NASDAQ:IDXX
Market	STOCKS
Sector	Healthcare
Industry	Medical - Diagnostics & Research
Country	US
Stage
Employee Count	11K
Website	idexx.com
LinkedIn
Founders

Metric
Market Cap	39.92B
Enterprise Value	47.99B
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	3.66B
Revenue (LTM)	3.96B
Revenue (NTM)	4.34B
Gross Profit	2.19B
EBITDA	1.10B
Operating Income	1.10B
Net Income	845.04M
EPS	10.17
Diluted EPS	10.06
Revenue 2022	3.37B
Revenue 2023	3.66B
Revenue 2024	3.97B
Revenue 2025	4.38B
Revenue 2026	4.83B

Metric
Revenue Growth (LTM)	0.08
Revenue Growth (NTM)	0.10
Gross Profit Growth (LTM)	3.99
EBITDA Growth (LTM)	-0.08
Net Income Growth (LTM)	0.07
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.60
Operating Profit Margin	0.30
EBITDA Margin	0.30
Net Profit Margin	0.23
Return on Equity	0.72
Return on Assets	0.26
Return on Capital Employed	0.48

NASDAQ:IDXX

IDEXX

Last Close

418.55

22/11 21:00

Market Cap

39.92B

Beta: 1.19

Volume Today

487.13K

Avg: 394.50K

PE Ratio

57.52

PFCF: 68.57

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	57.52
P/B Ratio	36.48
Revenue Multiple (LTM)	12.12
Revenue Multiple (NTM)	11.07
EBITDA Multiple (LTM)	47.69
EBITDA Multiple (NTM)	43.77
Price to Sales Ratio	12.16
EV Multiple	39.75

Metric
Days Sales Outstanding	46.05
Days Payables Outstanding	28.56
Days Inventory Outstanding	96.02
Operating Cycle	152.68
Cash Conversion Cycle	123.81
Asset Turnover	1.12

Metric
Operating Cash Flow	906.51M
Free Cash Flow	772.88M
Cash Flow to Debt	1.03
Operating Cash Flow/Sales	0.26
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	453.93M
Accounts Receivable	-53.87M
Inventory	380.28M
Goodwill	365.96M
Debt to Capitalization	0.41
Debt to Assets	0.33
Current Ratio	1.43
Quick Ratio	1.16

Metric
Rule of 40 (LTM)	0.34
Rule of 40 (NTM)	0.36
Stock Comp to Revenue	0.01
R&D to Revenue	0.05
SG&A to Revenue	0.09